» Articles » PMID: 32243770

Crossing Signals: Bioactive Lipids in the Microvasculature

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

The primary function of the arterial microvasculature is to ensure that regional perfusion of blood flow is matched to the needs of the tissue bed. This critical physiological mechanism is tightly controlled and regulated by a variety of vasoactive compounds that are generated and released from the vascular endothelium. Although these substances are required for modulating vascular tone, they also influence the surrounding tissue and have an overall effect on vascular, as well as parenchymal, homeostasis. Bioactive lipids, fatty acid derivatives that exert their effects through signaling pathways, are included in the list of vasoactive compounds that modulate the microvasculature. Although lipids were identified as important vascular messengers over three decades ago, their specific role within the microvascular system is not well defined. Thorough understanding of these pathways and their regulation is not only essential to gain insight into their role in cardiovascular disease but is also important for preventing vascular dysfunction following cancer treatment, a rapidly growing problem in medical oncology. The purpose of this review is to discuss how biologically active lipids, specifically prostanoids, epoxyeicosatrienoic acids, sphingolipids, and lysophospholipids, contribute to vascular function and signaling within the endothelium. Methods for quantifying lipids will be briefly discussed, followed by an overview of the various lipid families. The cross talk in signaling between classes of lipids will be discussed in the context of vascular disease. Finally, the potential clinical implications of these lipid families will be highlighted.

Citing Articles

Predictive value of total cholesterol to high-density lipoprotein cholesterol ratio for chronic kidney disease among adult male and female in Northwest China.

Liu Y, Lyu K, Liu S, You J, Wang X, Wang M Chronic Dis Transl Med. 2024; 10(3):216-226.

PMID: 39027193 PMC: 11252436. DOI: 10.1002/cdt3.122.


Critical Role of Mitochondrial Fatty Acid Metabolism in Normal Cell Function and Pathological Conditions.

Dikalov S, Panov A, Dikalova A Int J Mol Sci. 2024; 25(12).

PMID: 38928204 PMC: 11203650. DOI: 10.3390/ijms25126498.


Structural basis of prostaglandin efflux by MRP4.

Pourmal S, Green E, Bajaj R, Chemmama I, Knudsen G, Gupta M Nat Struct Mol Biol. 2024; 31(4):621-632.

PMID: 38216659 PMC: 11145372. DOI: 10.1038/s41594-023-01176-4.


Role of ceramides in diabetic foot ulcers (Review).

Wang Y, Sun Z, Zang G, Zhang L, Wang Z Int J Mol Med. 2023; 51(3).

PMID: 36799149 PMC: 9943538. DOI: 10.3892/ijmm.2023.5229.


The Plasma Oxylipin Signature Provides a Deep Phenotyping of Metabolic Syndrome Complementary to the Clinical Criteria.

Dalle C, Tournayre J, Mainka M, Basiak-Rasala A, Petera M, Lefevre-Arbogast S Int J Mol Sci. 2022; 23(19).

PMID: 36232991 PMC: 9570185. DOI: 10.3390/ijms231911688.


References
1.
Pokreisz P, Fleming I, Kiss L, Barbosa-Sicard E, Fisslthaler B, Falck J . Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling. Hypertension. 2006; 47(4):762-70. PMC: 1993904. DOI: 10.1161/01.HYP.0000208299.62535.58. View

2.
Holland W, Summers S . Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev. 2008; 29(4):381-402. PMC: 2528849. DOI: 10.1210/er.2007-0025. View

3.
Sarker M, Hu D, Fraser P . Regulation of cerebromicrovascular permeability by lysophosphatidic acid. Microcirculation. 2010; 17(1):39-46. DOI: 10.1111/j.1549-8719.2010.00001.x. View

4.
Nagao K, Yanagita T . Bioactive lipids in metabolic syndrome. Prog Lipid Res. 2008; 47(2):127-46. DOI: 10.1016/j.plipres.2007.12.002. View

5.
Cuvillier O, Pirianov G, Kleuser B, Vanek P, Coso O, Gutkind S . Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 1996; 381(6585):800-3. DOI: 10.1038/381800a0. View